Volume 90 Issue 31 | p. 21 | Concentrates
Issue Date: July 30, 2012

ScinoPharm To Supply Obesity Drug Active

Department: Business
Keywords: obesity, Taiwan, topiramate, epilepsy

Taiwan’s ScinoPharm will supply the drug company Vivus with a key active pharmaceutical ingredient for the obesity drug Qsymia. Approved by FDA earlier this month, Qsymia combines the anticonvulsant topiramate, which ScinoPharm will supply, and the appetite suppressant phentermine. ScinoPharm says it started supplying topiramate to Vivus during Qsymia’s clinical development. The Taiwanese firm first made generic topiramate, which is also used to treat epilepsy and nervous system disorders, two years ago.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment